Feb 23, 2016
Bill Roth, Founder and President, Blue Fin Group, consultants to the healthcare industry, talks about the impact of expiring blockbuster drugs, appealing to specialty populations, getting to value based outcomes for expensive drugs, and how patients need to be more accountable for their own health.
@bluefingroup